Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Dihydroergocristine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Curia
    U.S.A
    		 CURIA ITALY S.R.L. Rozzano, Milano IT R1-CEP 2000-073 - Rev 07 Dihydroergocristine mesilate 2023-03-14 Valid Chemical 1416
    28/10/2024 TAPI Technology & API Services
    Israel
    		 TEVA CZECH INDUSTRIES S.R.O. Opava CZ R1-CEP 2001-381 - Rev 03 Dihydroergocristine mesilate 2012-08-02 Withdrawn by Holder Chemical 2023-05-04 1416